La Jolla Pharmaceutical Company 13D and 13G filings for TETRAPHASE PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-29 5:18 pm Purchase | 2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 7,263,236 100.000% | 6,178,236 (+569.42%) | Filing |
| 2020-06-30 5:37 pm Unchanged | 2020-06-29 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 0 (Unchanged) | Filing |
| 2020-06-25 9:58 pm Unchanged | 2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 0 (Unchanged) | Filing |
| 2020-06-22 5:17 pm Purchase | 2020-06-15 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 1,085,000 (New Position) | Filing |